Patents by Inventor Nicolas Newton

Nicolas Newton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10689718
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Grant
    Filed: June 2, 2017
    Date of Patent: June 23, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Patent number: 10358675
    Abstract: Methods and oligonucleotides are provided for detecting an internal control nucleic acid for qualitative and/or quantitative purposes.
    Type: Grant
    Filed: July 24, 2018
    Date of Patent: July 23, 2019
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Ellen H. Fiss, Nicolas Newton
  • Publication number: 20180327840
    Abstract: Methods and oligonucleotides are provided for detecting an internal control nucleic acid for qualitative and/or quantitative purposes.
    Type: Application
    Filed: July 24, 2018
    Publication date: November 15, 2018
    Inventors: Ellen H. Fiss, Nicolas Newton
  • Patent number: 10059993
    Abstract: Methods and oligonucleotides are provided for detecting an internal control nucleic acid for qualitative and/or quantitative purposes.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: August 28, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Ellen H. Fiss, Nicolas Newton
  • Publication number: 20180046766
    Abstract: A hardware device and/or software system providing a method of timestamping, indexing, securing, and transmitting biomedical information (such as DNA sequences, patient chart notes, lab tests, diagnoses, radiology results, and similar information) along with metadata associated with this information (such as date, time, author); using a public or private distributed cryptographic hash ledger method to create a stable, tamperproof index that permits auditing and tracing information transit over an or several electronic networks/transmission methods; optionally compressing and/or encrypting information using secure encryption methods such as quantum-safe/quantum-secure/quantum-resilient methods that secures the key and the payload independently, and then storing the information on a local electronic device or computer, such as a DNA sequencing machine, or transmitting the information over an electronic network or storing it on a removable device.
    Type: Application
    Filed: June 26, 2017
    Publication date: February 15, 2018
    Inventors: Andrew DEONARINE, Railton FRITH, Nicolas NEWTON, Olivier Francois Roussy NEWTON
  • Publication number: 20170268074
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Application
    Filed: June 2, 2017
    Publication date: September 21, 2017
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Patent number: 9702017
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Grant
    Filed: April 17, 2013
    Date of Patent: July 11, 2017
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Patent number: 9506111
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, but having a 3?-terminal nucleotide complementary to only one variant of the target sequence and having at least one nucleotide with a base covalently modified at the exocyclic amino group, wherein the allele-specific oligonucleotide is extended by a nucleotide-incorporating biocatalyst predominantly when hybridized to the variant of the target sequence for which it has said complementary 3?-terminal nucleotide.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: November 29, 2016
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Stephen G. Will, Alison Tsan, Nicolas Newton
  • Publication number: 20160060694
    Abstract: Methods and oligonucleotides are provided for detecting an internal control nucleic acid for qualitative and/or quantitative purposes.
    Type: Application
    Filed: August 27, 2015
    Publication date: March 3, 2016
    Inventors: Ellen H. Fiss, Nicolas Newton
  • Patent number: 9238832
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, having an internally-placed selective nucleotide complementary to only one variant of the target sequence wherein the allele-specific oligonucleotide is extended by a nucleic acid polymerase predominantly or exclusively when hybridized to the variant of the target sequence for which it has said complementary selective nucleotide.
    Type: Grant
    Filed: December 8, 2010
    Date of Patent: January 19, 2016
    Assignee: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Alison Tsan, Nicolas Newton
  • Patent number: 9175332
    Abstract: The present invention provides a method for the amplification of at least a first and a second target nucleic acid that may be present in a fluid sample. The invention further provides a kit and an analytical system for carrying out said amplification.
    Type: Grant
    Filed: July 27, 2011
    Date of Patent: November 3, 2015
    Assignee: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Meike Eickhoff, Niclas Hitziger, Anke Mussmann, Thomas W. Myers, Christopher Newhouse, Nicolas Newton, John Niemiec, Nancy Schoenbrunner, Edward S. Smith, Stephen G. Will, Heike Wilts, Dirk Zimmermann
  • Publication number: 20150176060
    Abstract: The present invention provides for methods and compositions that use fluorescent dyes for the identification of reagents and solutions that are used to perform PCR assays.
    Type: Application
    Filed: December 8, 2014
    Publication date: June 25, 2015
    Inventors: Amar Gupta, Nancy Schoenbrunner, Kevin Janssen, Nicolas Newton
  • Publication number: 20140242592
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, but having a 3?-terminal nucleotide complementary to only one variant of the target sequence and having at least one nucleotide with a base covalently modified at the exocyclic amino group, wherein the allele-specific oligonucleotide is extended by a nucleotide-incorporating biocatalyst predominantly when hybridized to the variant of the target sequence for which it has said complementary 3?-terminal nucleotide.
    Type: Application
    Filed: October 11, 2013
    Publication date: August 28, 2014
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Stephen G. Will, Alison Tsan, Nicolas Newton
  • Patent number: 8614071
    Abstract: The present invention relates to a method, oligonucleotides, reaction mixtures and kits for the selective amplification of a messenger RNA target comprising an exon-exon junction, using an oligonucleotide that comprises at least one nucleotide modified at the exocyclic amino group.
    Type: Grant
    Filed: December 8, 2010
    Date of Patent: December 24, 2013
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Stephen Will, Lori Steiner, Alison Tsan, Nicolas Newton
  • Patent number: 8586299
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, but having a 3?-terminal nucleotide complementary to only one variant of the target sequence and having at least one nucleotide with a base covalently modified at the exocyclic amino group, wherein the allele-specific oligonucleotide is extended by a nucleotide-incorporating biocatalyst predominantly when hybridized to the variant of the target sequence for which it has said complementary 3?-terminal nucleotide.
    Type: Grant
    Filed: October 20, 2009
    Date of Patent: November 19, 2013
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Stephen G. Will, Alison Tsan, Nicolas Newton
  • Publication number: 20130280697
    Abstract: A method of simultaneously amplifying genotypes 1, 2, 3 and/or 4 of HEV is disclosed comprising amplifying the genotypes 1, 2, 3 and/or 4 of HEV with one single none-degenerate forward primer partially overlapping the 5?UTR region of HEV and at least one reverse primer. Also disclosed are related methods comprising a probe, and kits for the detection of genotypes 1, 2, 3 and/or 4 of HEV.
    Type: Application
    Filed: April 17, 2013
    Publication date: October 24, 2013
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Hermann Leying, Thomas W. Myers, Nicolas Newton, Eberhard Russmann, Joseph San Filippo, Nancy Schoenbrunner, Heike Wilts, Xiaoning Wu, Karen K. Y. Young, Dirk Zimmermann
  • Publication number: 20120190008
    Abstract: The present invention provides a method for the amplification of at least a first and a second target nucleic acid that may be present in a fluid sample. The invention further provides a kit and an analytical system for carrying out said amplification.
    Type: Application
    Filed: July 27, 2011
    Publication date: July 26, 2012
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Meike Eickhoff, Niclas Hitziger, Anke Mussmann, Thomas W. Myers, Christopher Newhouse, Nicolas Newton, John Niemiec, Nancy Schoenbrunner, Edward S. Smith, Stephen G. Will, Heike Wilts, Dirk Zimmermann
  • Publication number: 20110311968
    Abstract: The present invention includes a method of allele-specific amplification, utilizing an allele-specific oligonucleotide, at least partially complementary to more than one variant of the target sequence, having an internally-placed selective nucleotide complementary to only one variant of the target sequence wherein the allele-specific oligonucleotide is extended by a nucleic acid polymerase predominantly or exclusively when hybridized to the variant of the target sequence for which it has said complementary selective nucleotide.
    Type: Application
    Filed: December 8, 2010
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Alison Tsan, Nicolas Newton
  • Publication number: 20110312040
    Abstract: The present invention relates to a method, oligonucleotides, reaction mixtures and kits for the selective amplification of a messenger RNA target comprising an exon-exon junction, using an oligonucleotide that comprises at least one nucleotide modified at the exocyclic amino group.
    Type: Application
    Filed: December 8, 2010
    Publication date: December 22, 2011
    Applicant: ROCHE MOLECULAR SYSTEMS, INC.
    Inventors: Stephen Will, Lori Steiner, Alison Tsan, Nicolas Newton
  • Patent number: 8071338
    Abstract: Methods and compositions for amplification of a target sequence by suppressing amplification of related sequences are provided.
    Type: Grant
    Filed: August 5, 2008
    Date of Patent: December 6, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventor: Nicolas Newton